retatrutide precisa de receita vem ganhando atenção como o “próximo grande avanço” no tratamento da obesidade e diabetes tipo 2. Mas atenção: até hoje, não há versão aprovada oficialmente para prescrição. Qualquer oferta fora Retatrutide como alternativa a tirzepatida

Conclusions This study represents the largest cohort to date showing that GLP-1 RAs use in KTRs with T2DM is associated with reduced risks of mortality, as well as adverse cardiovascular and kidney outcomes, compared to nonuse

Peak Australian diabetes and medical bodies, consider that "DSNFs may be a valuable consideration to enhancing overall protein and nutritional intake for individuals treated with GLP-1 Receptor Agonist (GLP-1a) medications who are at increased risk of lean muscle mass loss

Oprea, A

G.WitteM

Sodiumglucose cotransporter 2 (SGLT2) inhibitors have emerged as cornerstone agents in DKD treatment, conferring substantial renoprotective benefits beyond glycemic control